» Articles » PMID: 9591010

Diarrhea After Resection of Advanced Abdominal Neuroblastoma: a Common Management Problem

Overview
Journal Surgery
Specialty General Surgery
Date 1998 May 20
PMID 9591010
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: After resection of advanced abdominal neuroblastoma, children may have persistent postoperative diarrhea. Until recently, the magnitude of this problem had not been appreciated.

Methods: To assess the incidence, severity, and management of chronic postoperative diarrhea in these patients, we reviewed the case notes of all children with stage III or IV abdominal and pelvic neuroblastoma who underwent tumor resection in our hospital between January 1985 and September 1996. We classified the severity of diarrhea as follows: mild, less than 3 loose stools per day; moderate, 3 to 5 loose stools per day; and severe, more than 5 loose stools per day and/or urgency, incontinence, or nocturnal diarrhea.

Results: Seventy-seven children underwent resection during this period, and 23 (30%) had postoperative diarrhea, classified as mild in 11 patients, moderate in 7, and severe in 5. Dissection around the superior mesenteric and celiac arteries was associated with a significantly higher incidence of diarrhea. Fifteen children (65%) received treatment with loperamide, which reduced but did not abolish symptoms. Twelve children subsequently died of progressive neuroblastoma. Of the 11 surviving children (mean duration of follow-up, 8.4 years), 8 have persistent loose stools.

Conclusions: Diarrhea, probably resulting from disruption of the autonomic nerve supply to the gut during clearance of tumor from the major vessels of the retroperitoneum, is common after resection of advanced abdominal neuroblastoma. Many children require long-term treatment to slow intestinal peristalsis, and a few have severe and unremitting diarrhea. More effective medical management of this complication is needed.

Citing Articles

Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Flaadt T, Rehm J, Simon T, Hero B, Ladenstein R, Lode H Cancers (Basel). 2025; 17(1.

PMID: 39796776 PMC: 11720496. DOI: 10.3390/cancers17010149.


Perioperative complication incidence and risk factors for retroperitoneal neuroblastoma in children: analysis of 571 patients.

He M, Cai J, Wu X, Tang Y, Wang J, Mao J World J Pediatr. 2023; 20(3):250-258.

PMID: 38070095 PMC: 10957663. DOI: 10.1007/s12519-023-00773-z.


International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Abib S, Chui C, Cox S, Abdelhafeez A, Fernandez-Pineda I, Elgendy A Ecancermedicalscience. 2022; 16:1356.

PMID: 35510137 PMC: 9023308. DOI: 10.3332/ecancer.2022.1356.


Bowel function and quality of life after minimally invasive colectomy with D3 lymphadenectomy for right-sided colon adenocarcinoma.

Lee K, Baek S, Kwak J, Kim J, Kim S World J Gastroenterol. 2020; 26(33):4972-4982.

PMID: 32952343 PMC: 7476173. DOI: 10.3748/wjg.v26.i33.4972.


Photo-Magnetic Irradiation-Mediated Multimodal Therapy of Neuroblastoma Cells Using a Cluster of Multifunctional Nanostructures.

Atluri R, Atmaramani R, Tharaka G, McCallister T, Peng J, Diercks D Nanomaterials (Basel). 2018; 8(10).

PMID: 30274306 PMC: 6215308. DOI: 10.3390/nano8100774.